CAMKK2 and prostate carcinoma: To assess the impact of CaMKK2 on membrane trafficking and organelle structure, we generated a stable knockdown of CAMKK2 in a prostate cancer cell line, LNCaP, using two independent shRNA constructs (Fig. 3A).